Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Haematological cancer

The translocation behind follicular lymphoma development

Healthy individuals carrying the t(14;18) translocation might never develop follicular lymphoma (FL). However, individuals with more than 1 in 10,000 cells carrying this translocation are at high-risk of developing FL. The identification of this high-risk population will help define the pathways driving FL and designing targeted therapies to use before its development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

References

  1. Roulland, S. et al. Early steps of follicular lymphoma pathogenesis. Adv. Immunol. 111, 1–46 (2011).

    Article  CAS  Google Scholar 

  2. Roulland, S. et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J. Exp. Med. 203, 2425–2431 (2006).

    Article  CAS  Google Scholar 

  3. Roulland, S. et al. t(14;18) Translocation: a predictive blood biomarker for follicular lymphoma. J. Clin. Oncol. 32, 1347–1355 (2014).

    Article  Google Scholar 

  4. Salles, G. et al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet 377, 42–51 (2011).

    Article  CAS  Google Scholar 

  5. Green, M. et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121, 1604–1611 (2013).

    Article  CAS  Google Scholar 

  6. Okosun, J. et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat. Genet. 46, 176–181 (2014).

    Article  CAS  Google Scholar 

  7. Pasqualucci, L. et al. Genetics of follicular lymphoma transformation. Cell Rep. 6, 130–140 (2014).

    Article  CAS  Google Scholar 

  8. Murawski, N. & Pfreundschuh, M. New drugs for aggressive B-cell and T-cell lymphomas. Lancet Oncol. 11, 1074–1085 (2010).

    Article  CAS  Google Scholar 

  9. Sarkozy, C. et al. Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma. Blood 123, 2740–2742 (2014).

    Article  CAS  Google Scholar 

  10. US National Library of Medicine. ClinicalTrials.govhttps://clinicaltrials.gov/ct2/show/NCT01476787?term=NCT01476787&rank=1 (2014).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bertrand Coiffier.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarkozy, C., Coiffier, B. The translocation behind follicular lymphoma development. Nat Rev Clin Oncol 11, 444–445 (2014). https://doi.org/10.1038/nrclinonc.2014.100

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2014.100

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer